SUBSCRIPTION
AGREEMENT
EFT
BIOTECH HOLDINGS, Inc.
Up to
10,000,000 Units/USD $3.80 per Unit
Each
Unit Consisting of One Share of Common Stock
And
One Two-Year Warrant Exercisable at USD $3.80 per
Share
For
Non-U.S. Purchasers
Pursuant
to Regulation S
EFT
BioTech Holdings, Inc., a Nevada corporation (the
“Company”), is offering to sell to the undersigned
Units of the Company at the purchase price of USD $3.80 per Unit
(the “Units”). Each Unit consists of one share of
common stock, $0.0001 par value per share of the Company (the
“Unit Share”) and one two-year redeemable common stock
purchase warrant (the “Warrant”). The
Warrant is exercisable to purchase one share of common stock of the
Company at USD $3.80 per share at any time from the date of
issuance until the second anniversary date of the date of issuance
(the “Warrant Shares” and together with the Units,
Units Shares and Warrants, the
“Securities”). The Warrants are redeemable, on a pro
rata basis, by the Company at a purchase price of USD $0.0001 per
Warrant 30 days from the 10 th
consecutive
trading day that the closing sales price, or the average of the
closing bid and asked price in the event that the Company’s
common stock trades on the OTC or any public securities market
within the U.S., of the Company’s common stock is at least
USD $11.00. The minimum investment is 300 Units (USD $1,140),
except we may accept subscriptions for lesser amounts with the
consent of Buckman, Buckman & Reid, Inc., the placement agent
of the Units (“Buckman” or the “Placement
Agent”). Offers and sales of the Units will be
made by the Placement Agent on a “best efforts” basis
only to non-U.S. Persons as defined in, and pursuant to, Regulation
S under the Securities Act of 1933, as amended (“Securities
Act”) (the “Offering”).
THAT
THE SECURITIES WILL BE MADE AVAILABLE ONLY TO NON-U.S. RESIDENTS
UNDER REGULATION S PROMULGATED UNDER THE SECURITIES ACT. THE
SECURITIES OFFERED HEREBY ARE BEING OFFERED PURSUANT TO AN
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND APPLICABLE STATE SECURITIES LAWS FOR OFFERINGS OUTSIDE THE
UNITED STATES. SUCH EXEMPTIONS LIMIT THE NUMBER AND TYPES OF
INVESTORS TO WHICH THE OFFERING WILL BE MADE AND RESTRICT
SUBSEQUENT SALES AND/OR TRANSFERS OF THE SECURITIES WITHIN THE
UNITED STATES.
AN
APPLICATION FOR THE UNITS IS NOT INVITED FROM ANY PERSONS IN HONG
KONG OTHER THAN A PERSON TO WHOM A COPY OF THE OFFERING MATERIALS
HAS BEEN ISSUED BY US, AND IF MADE, WILL NOT BE ACCEPTED, UNLESS
THE APPLICANT SATISFIES US THAT HE IS A PROFESSIONAL INVESTOR
WITHIN THE MEANING OF THE SECURITIES AND FUTURES ORDINANCE (CHAPTER
571 OF THE LAWS OF HONG KONG) .
1. The
undersigned hereby subscribes for the number of Units set forth on
the signature page below at a purchase price of $3.80 per
Unit.
2. Enclosed
is a check made payable to the “United Commercial Bank as
Escrow Agent for EFT BioTech Holdings, Inc.” or confirmation
of a wire transfer in accordance with the following instructions,
in the full amount of the purchase price of the Units subscribed
for:
|
|
|
|
|
|
|
1228
S. Baldwin Ave, Arcadia CA 91007
|
|
|
|
|
|
EFT
BioTech Holdings Escrow Account
|
|
|
Subscriber’s
Acknowledgements and Agreements .
|
The
undersigned understands, acknowledges and agrees that:
1. This
subscription may be accepted or rejected in whole or in part by the
Company and the Placement Agent, in their sole
discretion.
2. Except
as provided under applicable securities laws, this subscription is
and shall be irrevocable except that (i) the undersigned’s
execution and delivery of this Subscription Agreement will not
constitute an agreement between the Company, Placement
Agent and the undersigned until this Subscription
Agreement is accepted on behalf of the Company and, if not so
accepted, the undersigned’s subscription and obligations
hereunder will terminate and (ii) the undersigned can, at any time
prior to acceptance of this Subscription Agreement, request in
writing that the undersigned be released from the obligations
hereunder (and the Company may, but need not, in its discretion,
elect to release the undersigned from the subscription and from
such obligations).
3. No
federal, state, or foreign agency has made any findings or
determination as to the fairness of the terms of this
offering. The Securities have not been recommended or
endorsed by any U.S. federal or state securities commission or
regulatory agency or any foreign securities commission or
regulatory authority.
4. The
undersigned acknowledges that the Company has made no
representations with respect to registration of the Securities
under the Securities Act, that no such registration is
contemplated, and the undersigned must be prepared to bear the
economic risk of his/her investment for an indefinite period of
time.
5. The
following securities law matters are applicable to this
offering:
TO
ALL SUBSCRIBERS :
THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED
STATES OR TO U.S. PERSONS UNLESS PURSUANT TO REGULATION S OR THE
SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS
AVAILABLE. IT IS THE RESPONSIBILITY OF ANY INVESTOR
PURCHASING THE SECURITIES TO SATISFY ITSELF AS TO FULL OBSERVANCE
OF THE LAWS OF ANY RELEVANT TERRITORY OUTSIDE THE UNITED STATES IN
CONNECTION WITH ANY SUCH PERSON, INCLUDING OBTAINING ANY REQUIRED
GOVERNMENTAL OR OTHER CONSENTS AND OBSERVING ANY OTHER APPLICABLE
REQUIREMENTS.
WARNING:
TO
SUBSCRIBERS IN HONG KONG: THE
OFFERING MEMORANDUM RELATING TO THE SECURITIES HAS NOT BEEN
REVIEWED BY ANY REGULATORY AUTHORITY IN HONG KONG. YOU
ARE ADVISED TO EXERCISE CAUTION IN RELATION TO THE
OFFER. IF YOU ARE IN DOUBT ABOUT ANY OF THE CONTENTS OF
THIS DOCUMENT OR OF THE OFFERING MEMORANDUM RELATING TO THE
OFFERING OF THE SECURITIES, YOU SHOULD OBTAIN INDEPENDENT
PROFESSIONAL ADVICE.
THIS
DOCUMENT RELATES TO A SUBSCRIPTION FOR THE SECURITIES WHICH ARE
OFFERED IN A PRIVATE PLACEMENT AND IS NOT A
PROSPECTUS. NEITHER THIS SUBSCRIPTION AGREEMENT NOR THE
OFFERING MEMORANDUM RELATING TO THE SECURITIES CONSTITUTES OR FORMS
ANY PART OF AN OFFER, SOLICITATION OR INVITATION TO THE PUBLIC IN
HONG KONG TO SUBSCRIBE FOR, UNDERWRITE OR PURCHASE ANY SHARES OR
OTHER SECURITIES OR COMMITMENT WHATSOEVER. NEITHER THIS
DOCUMENT NOR THE OFFERING MEMORANDUM RELATING TO THE SECURTIES HAS
BEEN APPROVED BY THE SECURITIES AND FUTURES COMMISSION OF HONG
KONG, NOR HAS A COPY OF THE OFFERNG MEMORANDUM BEEN REGISTERED BY
THE REGISTRAR OF COMPANIES IN HONG KONG.
AN
APPLICATION FOR THE UNITS IS NOT INVITED FROM ANY PERSONS IN HONG
KONG OTHER THAN A PERSON TO WHOM A COPY OF THE OFFERING MATERIALS
HAS BEEN ISSUED BY US, AND IF MADE, WILL NOT BE ACCEPTED, UNLESS
THE APPLICANT SATISFIES US THAT HE IS A PROFESSIONAL INVESTOR
WITHIN THE MEANING OF THE SECURITIES AND FUTURES ORDINANCE (CHAPTER
571 OF THE LAWS OF HONG KONG) .
|
|
Subscriber’s
Representations and Warranties .
|
The
undersigned hereby represents and warrants to and further agrees
with the Company as follows:
1.
That
the Purchaser is not a resident of the United States and is
not purchasing the Securities within the United States or its
territories.
2.
That
the Purchaser is a “Professional Investor” within the
meaning of the securities and futures ordinance (Chapter 571 of the
laws of Hong Kong).
3.
The
undersigned understands and acknowledges that (a) the Securities
have not and will not be registered under the Securities Act, and
may not be offered or sold in the United States or to, or for the
account or benefit of, any “U.S. Person” (as defined in
Regulation S), unless such Securities are registered under the
Securities Act or such offer or sale is made pursuant to an
exemption from the registration requirements of the
Securi